Anixa Biosciences/$ANIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anixa Biosciences
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Ticker
$ANIX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
-
ISIN
US03528H1095
Website
ANIX Metrics
BasicAdvanced
$106M
-
-$0.38
0.33
-
Price and volume
Market cap
$106M
Beta
0.33
52-week high
$3.83
52-week low
$2.07
Average daily volume
186K
Financial strength
Current ratio
8.885
Quick ratio
8.266
Long term debt to equity
1.234
Total debt to equity
1.483
Profitability
Management effectiveness
Return on assets (TTM)
-39.75%
Return on equity (TTM)
-65.38%
Valuation
Price to book
6.62
Price to tangible book (TTM)
6.62
Price to free cash flow (TTM)
-13.304
Free cash flow yield (TTM)
-7.52%
Free cash flow per share (TTM)
-24.80%
Growth
Earnings per share change (TTM)
2.04%
3-year earnings per share growth (CAGR)
-10.17%
10-year earnings per share growth (CAGR)
6.92%
What the Analysts think about ANIX
Analyst ratings (Buy, Hold, Sell) for Anixa Biosciences stock.
ANIX Financial Performance
Revenues and expenses
ANIX Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Anixa Biosciences stock?
Anixa Biosciences (ANIX) has a market cap of $106M as of July 01, 2025.
What is the P/E ratio for Anixa Biosciences stock?
The price to earnings (P/E) ratio for Anixa Biosciences (ANIX) stock is 0 as of July 01, 2025.
Does Anixa Biosciences stock pay dividends?
No, Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next Anixa Biosciences dividend payment date?
Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Anixa Biosciences?
Anixa Biosciences (ANIX) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.